BioLineRx , a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for first quarter ended March 31, 2014.
http://ift.tt/1sQpk76
http://ift.tt/1sQpk76
No comments:
Post a Comment